ALDX

Aldeyra Therapeutics (ALDX)

About Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities related to general business planning, including raising capital. It focuses on the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Details

Daily high

$2.33

Daily low

$1.86

Price at open

52 Week High

$6.81

52 Week Low

$1.07

Market cap

134.2M

Dividend yield

0.00%

Volume

576

Avg. volume

6.2M

P/E ratio

-3.96

Aldeyra Therapeutics News